Charles Schwab’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790M | Buy |
1,773,625
+48,344
| +3% | +$21.5M | 0.14% | 133 |
|
|
2025
Q1 | $836M | Buy |
1,725,281
+61,432
| +4% | +$29.8M | 0.16% | 116 |
|
|
2024
Q4 | $670M | Buy |
1,663,849
+37,502
| +2% | +$15.1M | 0.12% | 138 |
|
|
2024
Q3 | $756M | Buy |
1,626,347
+20,361
| +1% | +$9.47M | 0.14% | 121 |
|
|
2024
Q2 | $753M | Buy |
1,605,986
+49,374
| +3% | +$23.1M | 0.14% | 127 |
|
|
2024
Q1 | $651M | Buy |
1,556,612
+47,406
| +3% | +$19.8M | 0.15% | 121 |
|
|
2023
Q4 | $614M | Buy |
1,509,206
+41,778
| +3% | +$17M | 0.16% | 114 |
|
|
2023
Q3 | $510M | Buy |
1,467,428
+17,564
| +1% | +$6.11M | 0.15% | 117 |
|
|
2023
Q2 | $510M | Buy |
1,449,864
+6,727
| +0.5% | +$2.37M | 0.15% | 121 |
|
|
2023
Q1 | $455M | Buy |
1,443,137
+27,109
| +2% | +$8.54M | 0.14% | 129 |
|
|
2022
Q4 | $409M | Buy |
1,416,028
+28,088
| +2% | +$8.11M | 0.13% | 146 |
|
|
2022
Q3 | $402M | Buy |
1,387,940
+23,848
| +2% | +$6.9M | 0.14% | 125 |
|
|
2022
Q2 | $384M | Buy |
1,364,092
+36,626
| +3% | +$10.3M | 0.13% | 139 |
|
|
2022
Q1 | $346M | Buy |
1,327,466
+65,778
| +5% | +$17.2M | 0.1% | 172 |
|
|
2021
Q4 | $277M | Buy |
1,261,688
+19,703
| +2% | +$4.33M | 0.08% | 217 |
|
|
2021
Q3 | $225M | Buy |
1,241,985
+25,546
| +2% | +$4.63M | 0.07% | 238 |
|
|
2021
Q2 | $245M | Buy |
1,216,439
+10,014
| +0.8% | +$2.02M | 0.08% | 212 |
|
|
2021
Q1 | $259M | Sell |
1,206,425
-54,152
| -4% | -$11.6M | 0.1% | 186 |
|
|
2020
Q4 | $298M | Sell |
1,260,577
-34,061
| -3% | -$8.05M | 0.12% | 159 |
|
|
2020
Q3 | $352M | Buy |
1,294,638
+58,738
| +5% | +$16M | 0.16% | 122 |
|
|
2020
Q2 | $359M | Buy |
1,235,900
+70,386
| +6% | +$20.4M | 0.18% | 112 |
|
|
2020
Q1 | $277M | Buy |
1,165,514
+36,925
| +3% | +$8.79M | 0.16% | 121 |
|
|
2019
Q4 | $247M | Buy |
1,128,589
+19,563
| +2% | +$4.28M | 0.13% | 144 |
|
|
2019
Q3 | $188M | Buy |
1,109,026
+38,797
| +4% | +$6.57M | 0.11% | 179 |
|
|
2019
Q2 | $196M | Buy |
1,070,229
+12,447
| +1% | +$2.28M | 0.12% | 160 |
|
|
2019
Q1 | $195M | Buy |
1,057,782
+78,875
| +8% | +$14.5M | 0.12% | 150 |
|
|
2018
Q4 | $162M | Buy |
978,907
+46,494
| +5% | +$7.7M | 0.12% | 154 |
|
|
2018
Q3 | $180M | Buy |
932,413
+25,205
| +3% | +$4.86M | 0.12% | 157 |
|
|
2018
Q2 | $154M | Sell |
907,208
-63,727
| -7% | -$10.8M | 0.11% | 169 |
|
|
2018
Q1 | $158M | Buy |
970,935
+19,759
| +2% | +$3.22M | 0.12% | 158 |
|
|
2017
Q4 | $143M | Buy |
951,176
+26,101
| +3% | +$3.91M | 0.11% | 164 |
|
|
2017
Q3 | $141M | Buy |
925,075
+36,216
| +4% | +$5.51M | 0.12% | 155 |
|
|
2017
Q2 | $115M | Buy |
888,859
+150,310
| +20% | +$19.4M | 0.11% | 185 |
|
|
2017
Q1 | $80.8M | Buy |
738,549
+42,718
| +6% | +$4.67M | 0.08% | 243 |
|
|
2016
Q4 | $51.3M | Buy |
695,831
+26,745
| +4% | +$1.97M | 0.06% | 324 |
|
|
2016
Q3 | $58.4M | Buy |
669,086
+15,414
| +2% | +$1.34M | 0.07% | 279 |
|
|
2016
Q2 | $56.2M | Buy |
653,672
+16,515
| +3% | +$1.42M | 0.07% | 283 |
|
|
2016
Q1 | $50.6M | Buy |
637,157
+12,045
| +2% | +$957K | 0.07% | 296 |
|
|
2015
Q4 | $78.7M | Buy |
625,112
+33,936
| +6% | +$4.27M | 0.11% | 178 |
|
|
2015
Q3 | $61.6M | Buy |
591,176
+11,518
| +2% | +$1.2M | 0.09% | 213 |
|
|
2015
Q2 | $71.6M | Buy |
579,658
+23,754
| +4% | +$2.93M | 0.1% | 198 |
|
|
2015
Q1 | $65.6M | Buy |
555,904
+23,367
| +4% | +$2.76M | 0.09% | 220 |
|
|
2014
Q4 | $63.3M | Buy |
532,537
+36,326
| +7% | +$4.32M | 0.09% | 213 |
|
|
2014
Q3 | $55.7M | Buy |
496,211
+9,275
| +2% | +$1.04M | 0.09% | 216 |
|
|
2014
Q2 | $46.1M | Buy |
486,936
+22,923
| +5% | +$2.17M | 0.08% | 250 |
|
|
2014
Q1 | $32.8M | Buy |
464,013
+11,929
| +3% | +$844K | 0.06% | 317 |
|
|
2013
Q4 | $33.6M | Buy |
452,084
+10,777
| +2% | +$801K | 0.06% | 288 |
|
|
2013
Q3 | $34M | Buy |
441,307
+263,916
| +149% | +$20.3M | 0.07% | 272 |
|
|
2013
Q2 | $14.3M | Buy |
+177,391
| New | +$14.3M | 0.03% | 472 |
|